Microbiologists are scientists who study microorganisms, including bacteria, viruses, fungi, and other microscopic life forms. In the realm of probiotics and prebiotics, they play a crucial role in understanding how beneficial bacteria interact with the human gut microbiome and contribute to overall health. Microbiologists focus on identifying and characterizing beneficial bacterial strains, such as Lactobacillus and Bifidobacterium. They analyze how these microbes survive in the digestive tract, their ability to promote gut balance, and their potential to treat digestive disorders like irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD). In prebiotic research, microbiologists examine how non-digestible fibers, such as inulin and fructooligosaccharides (FOS), selectively nourish beneficial gut bacteria. They explore the effects of prebiotics on microbiome composition, immune function, and metabolic health. Beyond gut health, microbiologists contribute to advancements in biotechnology, pharmaceuticals, and food science. Their research helps develop new probiotic and prebiotic products that improve digestion, enhance immunity, and support overall well-being. Through laboratory studies and clinical trials, microbiologists continue to expand our understanding of the microbiome and its role in human health.
Microbiologists use advanced techniques such as DNA sequencing, metagenomics, and microbial culturing to explore the diversity and functionality of gut bacteria. They investigate how probiotics help balance the microbiome, combat harmful pathogens, and enhance nutrient absorption. Additionally, they study how prebiotics selectively promote the growth of beneficial microbes, improving gut health and metabolic functions.
Title : Results from a cross-sectional observational study examining irritable bowel syndrome patients six months after finishing their participation in the ViIBS trial
Jacek Piatek, Calisia University, Poland
Title : Gut microbiome as a driver of healthy ageing
Thi Thu Hao Van, RMIT University, Australia
Title : Treating irritable bowel syndrome patients with a balanced multi-strain synbiotic–results from a multi-center, randomized, double-blind, placebo-controlled clinical trial (the ViIBS trial)
Henning Sommermeyer, Calisia University, Poland
Title : Molecular mechanisms underlying the anti-atherogenic actions of probiotics
Dipak P Ramji, Cardiff University, United Kingdom
Title : Global regulatory trends on the use of probiotics and prebiotics in foods and food supplements
David Pineda Ereno, DPE International Consulting, Belgium
Title : Biochemical profile and nutripotential glimpses of Terminalia arjuna bark extract
Suriyavathana Muthukrishnan, Periyar University, India